Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Asset Writedowns and Impairment (2021 - 2024)

Bio Essence (BIOE) has 2 years of Asset Writedowns and Impairment data on record, last reported at -$940.0 in Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$940.0; the TTM value through Dec 2024 reached $7295.0, changed N/A, while the annual FY2024 figure was $1.0 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached -$940.0 in Q4 2024 per BIOE's latest filing, down from $8235.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $8235.0 in Q4 2021 and bottomed at -$940.0 in Q4 2024.